Literature DB >> 22777884

Novel indanone derivatives as potential imaging probes for β-amyloid plaques in the brain.

Jin-Ping Qiao1, Chang-Sheng Gan, Chen-Wei Wang, Jin-Fang Ge, Dou-Dou Nan, Jian Pan, Jiang-Ning Zhou.   

Abstract

Molecular imaging probes to detect senile plaques (SPs) might help the early diagnosis of Alzheimer's disease (AD). In this study, a novel series of indanone derivatives were synthesized and characterized. In in vitro binding studies, compound 2e exhibited a K(i) value of 16 nM with a human AD brain homogenate. Although they displayed relatively low affinities for 2i and 2j--with K(i) values of 99 and 237 nM, respectively--the SPs in AD brain sections were positively stained by 2j. A method for in situ micro-autoradiography of AD brain was developed in this study and showed clear labeling of SPs by [(125)I]2i and [(125)I]2j. Both [(125)I]2i and [(125)I]2j had suitable lipophilicities and displayed high initial uptake and rapid clearance from the mouse brains. Furthermore, [(125)I]2i and [(125)I]2j were more stable in human brain homogenates than in mouse brain homogenates. These data suggest that such indanone derivatives might represent potential amyloid imaging agents for the detection of SPs in AD.
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777884     DOI: 10.1002/cbic.201200223

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  2 in total

1.  In vitro and in silico insights into tyrosinase inhibitors with (E)-benzylidene-1-indanone derivatives.

Authors:  Hee Jin Jung; Sang Gyun Noh; Yujin Park; Dongwan Kang; Pusoon Chun; Hae Young Chung; Hyung Ryong Moon
Journal:  Comput Struct Biotechnol J       Date:  2019-08-01       Impact factor: 7.271

2.  Melatonin binds with high affinity and specificity to beta-amyloid: LC-MS provides insight into Alzheimer's disease treatment.

Authors:  Yaqian Dai; Liduo Peng; Yajing Liu; Yuanhong Xu; Jinping Qiao
Journal:  FEBS Open Bio       Date:  2021-09-01       Impact factor: 2.693

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.